Recombinate: viral safety and final product manufacturing testing and specifications.
Lawrence
J
J
Baxter Healthcare Corporation, Hyland Division, Corporate Development, Glendale, CA 91203.
D000818:Animals; D000831:Animals, Newborn; D000911:Antibodies, Monoclonal; D000917:Antibody Formation; D016466:CHO Cells; D006224:Cricetinae; D004591:Electrophoresis, Polyacrylamide Gel; D005169:Factor VIII / Q000096:biosynthesis* / Q000302:isolation & purification / Q000592:standards; D006801:Humans; D007108:Immune Tolerance; D051379:Mice; D011994:Recombinant Proteins / Q000096:biosynthesis* / Q000302:isolation & purification / Q000592:standards
D000911:Antibodies, Monoclonal; D011994:Recombinant Proteins; C078147:F8 protein, human; D005169:Factor VIII